about
Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors.Cancer Stem Cell Signaling during Repopulation in Head and Neck Cancer.Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.PET-based radiation therapy planning.An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.Gene expression changes during repopulation in a head and neck cancer xenograft.Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.The world's first single-room proton therapy facility: Two-year experience.Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database.Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system.Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases.Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents.Risk factors for radiation-induced optic neuropathy: a case-control study.Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma.In reply to Gondi and Mehta.Magnetic resonance image guided radiation therapy for primary splenic diffuse large B-cell lymphoma: A teaching case.Eosinophilic granuloma of the sacrum treated with radiation therapy: a case report.Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy.A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer.Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.αvβ3 INTEGRIN MEDIATES RADIORESISTANCE OF PROSTATE CANCER CELLS THROUGH REGULATION OF SURVIVINHypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution ExperienceCharacterization and validation of an intra-fraction motion management system for masked-based radiosurgeryDetection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastomaHodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in OncologyNCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapyAssociation of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon TherapyManagement of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resectionStereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomesRadiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With ReirradiationAdherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model PolicyThe immune-related microRNA miR-146b is upregulated in glioblastoma recurrencePretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical ExperienceA multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
P50
Q31142342-E8B44FE2-C7F6-4EB0-A1FA-FEEFA0858B94Q35794637-A946E9E4-4802-4564-BA1C-F0FE679220A7Q36531535-51580BB1-9718-49E1-8D90-F086C90717F0Q36665022-05DED8CE-0B83-4521-BE3B-3AE90D60C141Q38279625-27E6A5BD-1EE2-4096-A3AB-89AFA830A906Q38366345-DCC6E785-FD86-4338-9E80-C5EFB938B64BQ38472267-88B2BF7B-131D-4E07-8A2B-BA79815B4D8DQ38948964-42E19370-202E-4FC5-82FD-34C0F327F69CQ38956483-ADD4A938-958D-42CC-A475-652C0B01162EQ39067273-933B1F9F-D03D-42ED-9C3A-219168592EDDQ40888212-03E062C3-5331-4494-BC74-EABAAFF7E250Q43379643-F2194D01-3718-4FB4-BD44-3CD056B1D1C8Q46294095-A5AB9A7F-ACF9-4BAF-8FF6-71000ECE361CQ47123941-EF44B574-ADD1-4744-9C4C-BB5A89E7F1C5Q47441447-B189CB7A-A49C-41CD-98FB-FF89DFCA74B1Q47577963-03CAC929-E143-4E6F-A875-44E4D1A3B50FQ48156573-6842F0BF-083A-4074-8DE3-71473CE54348Q48352488-7127A2E1-6B08-4F38-83DA-7E60ABAF1EBDQ50221532-FAC372B9-93F3-43FA-ADC9-7AC53B12D0B3Q50852060-41DE5715-A836-4B30-B7CC-C590D58024C4Q51744686-CC5C20A6-B48E-4BB4-B911-DB11657F221AQ52881176-FD2D051C-64AE-430F-A31E-D4655CBF8670Q53116048-41CAA9FB-2D5C-4073-95CB-83EF0533FB16Q53201325-4A50A573-ED00-4D6C-BB1D-C88E9DF13128Q57147619-C890830D-4D6F-44C9-85FA-04E1DC0B6948Q60146139-F63CF698-3B12-45CC-8287-A2CE8A6EB63DQ64067050-0ECAF396-E782-48FB-989B-EAFCBC2B372DQ64268794-A743496C-5C84-4937-AAD0-80473639F7A6Q88007869-AB63E818-2210-41E4-9C79-A0AD8E469483Q88013000-D813D6EF-0076-478D-B824-232E9A98ABA8Q88042928-4E04E037-4E91-48D7-81A9-61606C311856Q88043111-092F45E5-6B02-4C37-9237-60D29FDFF205Q88087150-7CCD426F-66BF-4A5E-B3C4-B49A93F01B8FQ89364373-AFE28698-07A9-49BE-9354-923CE08F3095Q89408288-B2181A44-3A41-4454-B648-DA3A92FC02DFQ89468789-166F5247-E389-4792-9B76-F5A763543854Q90298963-27C4739B-1EFB-48B8-B6D1-1490C4B4D81DQ91047969-B8715426-C0F8-475E-A3ED-99D7047AD83BQ91345420-6B896790-889D-4D80-9244-EB4290AFFDADQ91639840-1279ABF8-9BA7-473C-8A6A-4A0DC266EF48
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jiayi Huang
@ast
Jiayi Huang
@en
Jiayi Huang
@es
Jiayi Huang
@nl
Jiayi Huang
@sl
type
label
Jiayi Huang
@ast
Jiayi Huang
@en
Jiayi Huang
@es
Jiayi Huang
@nl
Jiayi Huang
@sl
prefLabel
Jiayi Huang
@ast
Jiayi Huang
@en
Jiayi Huang
@es
Jiayi Huang
@nl
Jiayi Huang
@sl
P106
P31
P496
0000-0002-5153-506X